MCID: PNM007
MIFTS: 69

Pneumonia

Categories: Respiratory diseases, Infectious diseases

Aliases & Classifications for Pneumonia

MalaCards integrated aliases for Pneumonia:

Name: Pneumonia 12 76 29 55 6 43 3 3 44 15 63 73
Acute Pneumonia 12 73

Classifications:



External Ids:

Disease Ontology 12 DOID:552
MeSH 44 D011014
NCIt 50 C3333

Summaries for Pneumonia

MedlinePlus : 43 Pneumonia is an infection in one or both of the lungs. Many germs, such as bacteria, viruses, and fungi, can cause pneumonia. You can also get pneumonia by inhaling a liquid or chemical. People most at risk are older than 65 or younger than 2 years of age, or already have health problems. Symptoms of pneumonia vary from mild to severe. See your doctor promptly if you Have a high fever Have shaking chills Have a cough with phlegm that doesn't improve or gets worse Develop shortness of breath with normal daily activities Have chest pain when you breathe or cough Feel suddenly worse after a cold or the flu Your doctor will use your medical history, a physical exam, and lab tests to diagnose pneumonia. Treatment depends on what kind you have. If bacteria are the cause, antibiotics should help. If you have viral pneumonia, your doctor may prescribe an antiviral medicine to treat it. Preventing pneumonia is always better than treating it. Vaccines are available to prevent pneumococcal pneumonia and the flu. Other preventive measures include washing your hands frequently and not smoking. NIH: National Heart, Lung, and Blood Institute

MalaCards based summary : Pneumonia, also known as acute pneumonia, is related to bronchopneumonia and idiopathic interstitial pneumonia, and has symptoms including coughing, fever and hemoptysis. An important gene associated with Pneumonia is LINC02258 (Long Intergenic Non-Protein Coding RNA 2258
These novel lncRNAs and their target genes may be closely associated with the progression of pneumonia.
Dysfunction Pattern: ), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Augmentin and Avelox I.V. have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and heart, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 A lung disease that involves lung parenchyma or alveolar inflammation and abnormal alveolar filling with fluid (consolidation and exudation). It results from a variety of causes including infection with bacteria, viruses, fungi or parasites, and chemical or physical injury to the lungs. It is accompanied by fever, chills, cough, and difficulty in breathing.

CDC : 3 Pneumocystis jirovecii in the lung of an HIV/AIDS patient.

PubMed Health : 63 About pneumonia: Pneumonia (nu-MO-ne-ah) is an infection in one or both of the lungs. Many germs—such as bacteria, viruses, and fungi—can cause pneumonia.The infection inflames your lungs' air sacs, which are called alveoli (al-VEE-uhl-eye). The air sacs may fill up with fluid or pus, causing symptoms such as a cough with phlegm (a slimy substance), fever, chills, and trouble breathing.

Wikipedia : 76 Pneumonia is an inflammatory condition of the lung affecting primarily the small air sacs known as... more...

Related Diseases for Pneumonia

Diseases in the Pneumonia family:

Viral Pneumonia

Diseases related to Pneumonia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1094)
# Related Disease Score Top Affiliating Genes
1 bronchopneumonia 34.0 CD40LG ELANE MPO
2 idiopathic interstitial pneumonia 34.0 CCL2 CXCL8 ELANE MUC5B SFTPC SFTPD
3 pneumocystosis 33.9 CD40LG SFTPD TNF
4 avian influenza 33.2 CXCL8 IL6 SFTPD TNF
5 q fever 33.0 CD40LG IL10 IL1B TLR2 TNF
6 invasive aspergillosis 32.9 CXCL8 SFTPD TLR2
7 bronchiolitis obliterans 32.8 CXCL8 IL10 IL6 MPO TNF
8 legionellosis 32.8 CD40LG TLR2 TLR5 TNF
9 pulmonary fibrosis, idiopathic 32.8 CCL2 CXCL8 ELANE IL1B MUC5B SFTPC
10 common variable immunodeficiency 32.8 CD40LG IL10 IL6 TNF
11 pulmonary hemosiderosis 32.7 CD40LG MPO MUC5B
12 adult respiratory distress syndrome 32.4 CXCL8 ELANE IL10 IL6 SFTPC TNF
13 melioidosis 32.2 IL10 IL6 TLR2 TLR5 TNF TREM1
14 respiratory failure 32.2 CRP CXCL8 ELANE SFTPC SFTPD TNF
15 bronchiolitis 32.2 CCL11 CD40LG CXCL8 IL10 IL6 MUC5B
16 toxic shock syndrome 31.9 CXCL8 IL10 IL1B IL6 TLR2 TNF
17 acute respiratory distress syndrome 31.9 CXCL8 ELANE IL1B IL6 SFTPC SFTPD
18 haemophilus influenzae 31.5 CXCL8 IL1B TLR2 TNF
19 hematopoietic stem cell transplantation 31.5 IL10 IL6 TNF
20 fasciitis 31.4 CXCL8 IL6 TNF
21 extrinsic allergic alveolitis 31.4 CCL2 CXCL8 IL10 IL1B IL6 MPO
22 transverse myelitis 31.3 CXCL8 IL10 IL6 TNF
23 interstitial lung disease 31.3 CCL2 CXCL8 IL10 IL1B IL6 MUC5B
24 aspergillosis 31.2 ELANE IL10 SFTPD TLR2
25 connective tissue disease 31.2 CD40LG IL10 IL6 SFTPD TNF
26 purpura 31.2 CD40LG CRP TNF
27 pericarditis 31.2 CRP IL1B IL6 TNF
28 laryngitis 31.2 IL1B IL6 TNF
29 chlamydia 31.2 CD40LG CRP CXCL8 IL10 IL1B IL6
30 pharyngitis 31.2 CRP CXCL8 IL1B
31 bacteriuria 31.2 CD40LG CXCL8 IL6
32 spondylitis 31.1 CD40LG CRP IL6 TNF
33 cytomegalovirus infection 31.1 CXCL8 IL10 IL6 TNF
34 anterior uveitis 31.1 CCL2 IL6 TLR2
35 mycobacterium abscessus 31.1 CXCL8 TLR2 TNF
36 arthritis 31.1 CCL2 CXCL8 IL10 IL1B IL6 TNF
37 viral infectious disease 31.1 CD40LG CXCL8 IL10 IL1B IL6 TNF
38 spondyloarthropathy 1 31.1 CD40LG CRP TNF
39 myelitis 31.1 CCL11 IL6 TNF
40 pulmonary fibrosis 31.0 CCL2 IL1B MUC5B SFTPC SFTPD
41 temporal arteritis 31.0 CCL2 CD40LG CRP IL6
42 acute transverse myelitis 31.0 CXCL8 IL10 IL6
43 ischemic heart disease 31.0 CRP IL6 TNF
44 myocarditis 31.0 CD40LG IL6 TNF
45 osteomyelitis 31.0 CXCL8 IL1B IL6 TNF
46 acquired immunodeficiency syndrome 31.0 CD40LG IL10 IL1B IL6 TNF
47 reactive arthritis 30.9 CRP IL10 IL6 TNF
48 bronchitis 30.9 CCL11 CD40LG CXCL8 ELANE MPO TNF
49 mixed connective tissue disease 30.9 CD40LG IL10 IL6 TNF
50 cold agglutinin disease 30.9 CRP IL6

Graphical network of the top 20 diseases related to Pneumonia:



Diseases related to Pneumonia

Symptoms & Phenotypes for Pneumonia

UMLS symptoms related to Pneumonia:


coughing, fever, hemoptysis, pruritus, snoring

MGI Mouse Phenotypes related to Pneumonia:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.17 IL6 CCL11 CD40LG MPO MUC5B CSF3
2 immune system MP:0005387 10.09 CCL2 CD40LG MPO CRP MUC5B CSF3
3 cardiovascular system MP:0005385 10.07 IL6 CD40LG MPO CRP SFTPC IL10
4 homeostasis/metabolism MP:0005376 10.07 IL6 CD40LG MPO CRP MUC5B ELANE
5 neoplasm MP:0002006 9.56 IL6 ELANE SFTPC IL10 TLR2 IL1B
6 respiratory system MP:0005388 9.28 IL6 CCL11 MUC5B SFTPC IL10 SFTPD

Drugs & Therapeutics for Pneumonia

PubMedHealth treatment related to Pneumonia: 63

Treatment for pneumonia depends on the type of pneumonia you have and how severe it is. Most people who have community-acquired pneumonia—the most common type of pneumonia—are treated at home.The goals of treatment are to cure the infection and prevent complications.

FDA approved drugs:

(show all 7)
# Drug Name Active Ingredient(s) 18 Company Approval Date
1
Augmentin 18 AMOXICILLIN; CLAVULANATE POTASSIUM SmithKline Beecham February 1996
2
Avelox I.V. 18 MOXIFLOXACIN HYDROCHLORIDE Bayer November 2001
3
Teflaro 18 CEFTAROLINE FOSAMIL Cerexa Nov-10
4
Tequin 18 Bristol-Myers Squibb December, 1999
5
Tygacil 18 TIGECYCLINE Wyeth 2005
6
Vibativ 18 * TELAVANCIN * TELAVANCIN HYDROCHLORIDE Theravance June 2013
7
Zosyn 18 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM Wyeth May 1996

Drugs for Pneumonia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1016)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7440-66-6 23994
2
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Not Applicable 137-58-6 3676
3
Tazobactam Approved Phase 4,Phase 2,Phase 3,Phase 1 89786-04-9 123630
4
Cilastatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 82009-34-5 5280454 6435415
5
Ceftriaxone Approved Phase 4,Phase 3,Phase 2,Not Applicable 73384-59-5 5479530 5361919
6
Sulfamethoxazole Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 723-46-6 5329
7
Amikacin Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 37517-28-5 37768
8
Menthol Approved Phase 4,Phase 2,Phase 1,Not Applicable 2216-51-5 16666
9
Enfuvirtide Approved, Investigational Phase 4,Phase 2,Not Applicable 159519-65-0 16130199
10
Tetracycline Approved, Vet_approved Phase 4,Phase 1,Early Phase 1 60-54-8 5353990
11
Nicotine Approved Phase 4,Not Applicable 54-11-5 942 89594
12
Simvastatin Approved Phase 4,Phase 3,Phase 1,Phase 2 79902-63-9 54454
13
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-23-7 5754
14
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 85721-33-1 2764
15
Sevoflurane Approved, Vet_approved Phase 4,Phase 1,Phase 2 28523-86-6 5206
16
Meropenem Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 119478-56-7 64778 441130
17
Erythromycin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 114-07-8 12560
18
Bupivacaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2180-92-9, 38396-39-3 2474
19
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 564-25-0 54671203
20
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7439-89-6 23925
21
Telithromycin Approved Phase 4,Phase 3,Phase 2 191114-48-4 5462516 0
22
Ganciclovir Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 82410-32-0 3454
23
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83905-01-5 55185 447043
24
Clarithromycin Approved Phase 4,Phase 3,Phase 2 81103-11-9 84029
25
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 73590-58-6 4594
26
Minocycline Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 10118-90-8 5281021
27
Penicillin G Approved, Vet_approved Phase 4,Phase 3 61-33-6 5904
28
Moxifloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 354812-41-2, 151096-09-2 152946
29
Budesonide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51333-22-3 63006 5281004
30
Trimethoprim Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 738-70-5 5578
31
Cefepime Approved, Investigational Phase 4,Phase 3,Not Applicable 88040-23-7 5479537
32
Cefoxitin Approved Phase 4,Phase 2 35607-66-0 441199
33
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
34
Tramadol Approved, Investigational Phase 4,Not Applicable 27203-92-5 33741
35
Ofloxacin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 82419-36-1 4583
36
Linezolid Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 165800-03-3 441401
37 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 979-32-8
38
Bosentan Approved, Investigational Phase 4,Phase 3,Phase 2 147536-97-8 104865
39
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 22916-47-8 4189
40
Oseltamivir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 204255-11-8, 196618-13-0 65028
41
Atropine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 5908-99-6, 51-55-8 174174
42
Rocuronium Approved Phase 4,Not Applicable 119302-91-9, 143558-00-3 441290
43
Tranexamic Acid Approved Phase 4,Phase 3,Not Applicable 1197-18-8 5526
44
Pirfenidone Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 53179-13-8 40632
45
Cyclophosphamide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 50-18-0, 6055-19-2 2907
46
Imipenem Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 74431-23-5, 64221-86-9 104838
47
Metronidazole Approved Phase 4,Phase 3,Phase 2,Not Applicable 443-48-1 4173
48
Colistin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1264-72-8, 1066-17-7 5311054
49
Calcium Carbonate Approved, Investigational Phase 4 471-34-1
50
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 185243-69-0

Interventional clinical trials:

(show top 50) (show all 3293)
# Name Status NCT ID Phase Drugs
1 Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU Patients Unknown status NCT01501227 Phase 4
2 Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatients Unknown status NCT02600806 Phase 4 Azithromycin;Levofloxacin
3 Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia Unknown status NCT01805284 Phase 4 Linezolid
4 Corticosteroid Therapy for Severe Community-Acquired Pneumonia Unknown status NCT02552342 Phase 4 methylprednisolone;Normal saline
5 Probiotics for Prevention of Ventilator-Associated Pneumonia (VAP) Unknown status NCT01301131 Phase 4
6 Duration of Antibiotic Therapy in Community - Acquired Pneumonia Unknown status NCT01492387 Phase 4
7 Ventilator-associated Pneumonia (VAP) and Humidification System Unknown status NCT01546974 Phase 4
8 Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia Unknown status NCT01356472 Phase 4 Imipenem/cilastatin
9 Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors Unknown status NCT00752947 Phase 4 moxifloxacin;levofloxacin;metronidazole
10 Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children. Unknown status NCT01883596 Phase 4 0.12% chlorhexidine solution;Placebo
11 Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study Unknown status NCT00936013 Phase 4 oseltamivir;oseltamivir and chinese medicinal herbs
12 SDD for Eradicating CRKP Carriage Unknown status NCT01761487 Phase 4
13 Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome Unknown status NCT02370550 Phase 4 Cyclosporin A;Prednisone;Placebo;Calcium carbonate D
14 PTH - Preemptive Treatment for Herpesviridae Unknown status NCT02152358 Phase 4 Aciclovir;Ganciclovir;Placebo
15 7-valent Pneumococcal Conjugated Vaccination Unknown status NCT00885625 Phase 4
16 Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections Unknown status NCT02171338 Phase 4
17 Lactobacillus Preparation on the Incidence of Diarrhea Unknown status NCT01792739 Phase 4 Lactobacillus casei variety rhamnosus granules;Placebo
18 Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection Unknown status NCT02054182 Phase 4 Vitamin D
19 Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine Unknown status NCT00152802 Phase 4
20 Optimizing Influenza Vaccination in Surgical Oncology Patients Unknown status NCT01698177 Phase 4
21 Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda Unknown status NCT00674921 Phase 4 cotrimoxazole;Placebo
22 Safety and Efficacy Study of High Dose Colistin Unknown status NCT02162966 Phase 4 High Dose Colistin;Standard Dose Colistin
23 Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study Unknown status NCT00637065 Phase 4 Bosentan;Placebo
24 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4 placebo;amoxicillin clavulanate acid
25 Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients Unknown status NCT01131806 Phase 4 fluticasone/ salmeterol 125/25 mcg/puff;fluticasone/ salmeterol 250/25 mcg/puff
26 LGG for Prevention of Infectious Complications During PPI Treatment in Children Unknown status NCT01782118 Phase 4
27 Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis Unknown status NCT01820026 Phase 4 Imipenem;Vancomycin;azithromycin;Cefotaxime;Amoxicillin
28 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
29 Prevention of Chronic Lung Disease (CLD) in Preterm Infants Unknown status NCT00883532 Phase 4 budesonide;surfactant and air (placebo)
30 Influence of Moderate Inspired Oxygen Fraction (FiO2) and Protective Ventilation on Postoperative Pulmonary Complication Unknown status NCT02198625 Phase 4
31 Comparative Study of Non-Invasive Mask Ventilation vs Cuirass Ventilation in Patients With Acute Respiratory Failure. Unknown status NCT00331656 Phase 4
32 Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD Unknown status NCT02504801 Phase 4 Budesonide
33 Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS) Unknown status NCT01573715 Phase 4 NIMBEX;NIMBEX
34 Comparing Treatment Efficacy With High and Medium Dose of Fluticasone in Combination With Salmeterol in COPD Patients Unknown status NCT01657487 Phase 4 Fluticasone/Salmeterol high dose
35 Effect of Enteral Genistein Supplementation in Sepsis Unknown status NCT02796794 Phase 4
36 Polysaccharide Antibody Response Study Unknown status NCT02429531 Phase 4
37 Influence of BCG on TDaP-IPV Vaccination Unknown status NCT02771782 Phase 4
38 Effect of Daily Nicotine Patch Application on Mechanical Ventilation Weaning in Smoking Patients Unknown status NCT01104896 Phase 4 Nicotine patch;Placebo
39 Diverticulitis: Antibiotics or Close Observation? Unknown status NCT01111253 Phase 4 Amoxicillin-clavulanate
40 Effect of Omega-3 Fatty Acids on the Perioperative Immune Response and Erythrocyte Function Unknown status NCT02231203 Phase 4 Omegaven;Placebo
41 A Study of Residual Curarization Incidence in China Unknown status NCT01690338 Phase 4 Vecuronium Bromide;Rocuronium;Cisatracurium
42 Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients Unknown status NCT01382368 Phase 4 Sildenafil
43 Comparisons of Inhaled LAMA or ICS+LABA for COPD With Bronchiectasis Unknown status NCT02546297 Phase 4 Symbicort;Tiotropium Bromide
44 Correlation Among Sperm DNA Fragmentation, Genitourinary Infection by Mycoplasma in Male and the Pregnancy Outcomes After IUI in Their Partner Unknown status NCT01555047 Phase 4
45 Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents Unknown status NCT02404779 Phase 4 cisatracurium besilate
46 Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Unknown status NCT01661985 Phase 4 Azithromycin;Doxycycline;lymecycline
47 The Effect of Chest Tubes Using Active Clearance Technology® on the Incidence of Postoperative Atrial Fibrillation Unknown status NCT02808897 Phase 4
48 Targeting of Immune Response After Pneumococcal Vaccination Completed NCT01402245 Phase 4
49 Home Management of Malaria and Pneumonia Completed NCT02151578 Phase 4
50 Vitamin D Supplementation and Respiratory Index of Severity in Children (RISC) in Pneumonia Completed NCT02936895 Phase 4 Vitamin D3;Placebo

Search NIH Clinical Center for Pneumonia

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: pneumonia

Genetic Tests for Pneumonia

Genetic tests related to Pneumonia:

# Genetic test Affiliating Genes
1 Pneumonia 29

Anatomical Context for Pneumonia

MalaCards organs/tissues related to Pneumonia:

41
Lung, Testes, Heart, Colon, Liver, Skin, Brain

Publications for Pneumonia

Articles related to Pneumonia:

(show top 50) (show all 6805)
# Title Authors Year
1
Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. ( 29389984 )
2018
2
Effect of starting oral intake on weekends on the clinical course of patients with aspiration pneumonia. ( 29780243 )
2018
3
Synthetic avenues towards a tetrasaccharide related to <i>Streptococcus pneumonia</i> of serotype 6A. ( 29977381 )
2018
4
Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia. ( 29773690 )
2018
5
A Randomized Controlled Trial to Investigate the Effectiveness of the Prevention of Aspiration Pneumonia Using Recommendations for Swallowing Care Guided by Ultrasound Examination. ( 29439537 )
2018
6
Chlamydia pneumoniae infection promotes monocyte transendothelial migration by increasing vascular endothelial cell permeability via the tyrosine phosphorylation of VE-cadherin. ( 29462613 )
2018
7
Purulent pericarditis, an unusual complication of pneumococcal pneumonia: a case report. ( 29322942 )
2018
8
Common variable immunodeficiency presenting in a man with recurrent pneumonia caused by <i>Staphylococcus lugdunensis</i>. ( 29559491 )
2018
9
Bronchiolitis obliterans organizing pneumonia after stereotactic ablative radiation therapy for lung cancer: A case report. ( 29395853 )
2018
10
Combined pharmacotherapy for osteonecrosis of the femoral head after severe acute respiratory syndrome and interstitial pneumonia: two and a half to fourteenA year follow-up. ( 29594456 )
2018
11
Association of serum high-mobility group box protein 1 level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. ( 29795561 )
2018
12
Bronchiolitis obliterans organising pneumonia as an initial manifestation in a patient with systemic lupus erythematosus: a rare presentation. ( 29804073 )
2018
13
Legionella Pneumonia Complicated with Acquired Fanconi Syndrome: A Case Report. ( 29877286 )
2018
14
Aspiration pneumonia induces muscle atrophy in the respiratory, skeletal, and swallowing systems. ( 29790300 )
2018
15
Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension. ( 29804068 )
2018
16
Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. ( 29290527 )
2018
17
Reply to the letter: &amp;quot;Pericardial effusion in community-acquired pneumonia: casuality or etiology?&amp;quot; ( 29735269 )
2018
18
Invasive pulmonary aspergillosis mimicking organizing pneumonia after mTOR inhibitor therapy: a case report. ( 29408183 )
2018
19
Osteoblasts Are Rapidly Ablated by Virus-Induced Systemic Inflammation following Lymphocytic Choriomeningitis Virus or Pneumonia Virus of Mice Infection in Mice. ( 29212906 )
2018
20
Using oral health assessment to predict aspiration pneumonia in older adults. ( 29446124 )
2018
21
Pulmonary Adenocarcinoma Mimicking Desquamative Interstitial Pneumonia: Report of 2 Cases With Genetic Analysis. ( 29720004 )
2018
22
Tigecycline application in a 3-month-old infant with multiple drug resistant <i>Klebsiella pneumonia</i>: a case report. ( 29977345 )
2018
23
Pneumomediastinum and Pneumothorax Associated with Herpes Simplex Virus (HSV) Pneumonia. ( 29379004 )
2018
24
Whole-genome sequence analysis of<i>Streptococcus pneumoniae</i>strains that cause hospital-acquired pneumonia infections. ( 29444837 )
2018
25
Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma. ( 28156016 )
2018
26
Treating nosocomial pneumonia: what's new. ( 29978856 )
2018
27
A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam. ( 29926399 )
2018
28
Comparison of Videofluoroscopic Swallowing Study and Radionuclide Salivagram for Aspiration Pneumonia in Children With Swallowing Difficulty. ( 29560324 )
2018
29
A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia. ( 29728109 )
2018
30
Ceftazidime/Avibactam for Refractory Bacteremia, Vertebral Diskitis/Osteomyelitis with Pre-Vertebral Abscess and Bilateral Psoas Pyomyositis Secondary to Klebsiella Pneumoniae Carbapenemase-Producing Bacteria (KPC). ( 29905925 )
2018
31
Maternal Influenza Immunization and Prevention of Severe Clinical Pneumonia in Young Infants: Analysis of Randomized Controlled Trials Conducted in Nepal, Mali, and South Africa. ( 29443825 )
2018
32
Pre-stroke undiagnosed dysphagia lusoria as a rare cause of aspiration pneumonia with respiratory failure in a stroke patient. ( 29552342 )
2018
33
Community-acquired bacterial pneumonia in adult HIV-infected patients. ( 29976111 )
2018
34
Monomicrobial Klebsiella pneumoniae necrotizing fasciitis: an emerging life-threatening entity. ( 29787886 )
2018
35
Serial chest CT in cryptogenic organizing pneumonia: Evolutional changes and prognostic determinants. ( 28960643 )
2018
36
Community acquired <i>Klebsiella pneumoniae</i> meningitis: a case report. ( 29951382 )
2018
37
Tuberculous pleurisy mimicking Mycoplasma pneumoniae infection in a previously healthy young adult: A case report. ( 29768381 )
2018
38
Empirical antibiotic treatment for children suffering from dysentery, cholera, pneumonia, sepsis or severe acute malnutrition. ( 29790843 )
2018
39
Acute eosinophilic pneumonia in the deployed military setting. ( 29605194 )
2018
40
One-Year Risk of Pneumonia and Mortality in Patients with Poststroke Dysphagia: A Nationwide Population-Based Study. ( 29395642 )
2018
41
Ventilator associated pneumonia caused by <i>Raoultella ornithinolytica</i> in two immunocompetent trauma patients. ( 29977781 )
2018
42
Guillain-BarrAc syndrome and optic neuritis after Mycoplasma pneumoniae infection. ( 29429558 )
2018
43
OK-432 pleurodesis for the treatment of pneumothorax in patients with interstitial pneumonia. ( 29903606 )
2018
44
<i>S. maltophilia</i> pneumonia: A case report. ( 29977756 )
2018
45
Clinical Characteristics of Pneumonia in Chinese Hemodialysis Patients. ( 29451161 )
2018
46
A case of cocaine-induced eosinophilic pneumonia: Case report and review of the literature. ( 29487790 )
2018
47
A recurrent case of eosinophilic pneumonia with high IL-25 levels. ( 29779833 )
2018
48
Bacteriological testing and recurrence prevention efforts in the diagnosis and treatment of nursing- and healthcare-associated pneumonia and aspiration pneumonia: A questionnaire survey of hospitals across Japan. ( 29548653 )
2018
49
Estimating the distribution of morbidity and mortality of childhood diarrhea, measles, and pneumonia by wealth group in low- and middle-income countries. ( 29970074 )
2018
50
Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia. ( 29970200 )
2018